Journal
BIOMEDICINES
Volume 9, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines9020097
Keywords
salivary gland carcinoma; PD-L1; PD-1; tumor periphery; tumor center; grade; stage; lymph node metastases
Categories
Funding
- Charles University-project GA UK [364218, PRIMUS/MED/12]
- Ministry of Health, Czech Republic [AZV 16-28135A, AZV 18-08-00229]
- Charles University, First Faculty of Medicine [Progres Q28]
Ask authors/readers for more resources
This research found that PD-1 and PD-L1 expression in salivary gland cancer patients primarily cluster in the tumor periphery, potentially predicting the response to immune checkpoint inhibitor therapy. Additionally, PD-1 positive tumor cells were mainly found in the center of high-grade tumors, and the presence of lymph node metastases and primary tumor stage significantly correlated with PD-L1 positive tumor cells in the tumor periphery.
The treatment options for patients with advanced salivary gland cancers (SGCs) are limited. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. However, the response to ICI immunotherapy is largely driven by the immune cell signatures within the tumor tissue and the para-tumoral tissue compartments. To date, there are no data on the expression of programed cell death protein-1/programed cell death protein-ligand 1 (PD-1/PD-L1) in SGC, which may enable the implementation of ICI immunotherapy for this disease. Thus, we performed an immunohistochemical analysis of PD-1 and PD-L1 expression in tumor cells and tumor-infiltrating immune cells (TIICs) in the tumor center and periphery of 62 SGC patients. The tumor periphery showed significantly higher expression of PD-L1 in tumor cells than in TIICs. Moreover, peripheral TIICs had significantly higher PD-1 expression than peripheral tumor cells. PD-1-positive tumor cells were detected exclusively in the tumor center of high-grade tumors, and most importantly, the presence of lymph node (LN) metastases and primary tumor stage significantly correlated with the presence of PD-L1-positive tumor cells in the tumor periphery. The PD-1 /PD-L1 molecular signatures in SGC are clustered predominantly in the tumor periphery, reflect disease severity, and may predict the response to ICI immunotherapy in SGC patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available